placebo-controlled [resa]
DOUBLE BLIND [resa]
Trial [resa]
Hypercholesterolaemia [dsyn]
Chemical [chem]
risk factors [qnco]
Cardiovascular disease [dsyn]
Primary Care [hlca]
setting [ftcn]
Lipid lowering drug [phsu]
Primary Care [hlca]
Cardiovascular disease [dsyn]
high cholesterol [fndg]
Several [qnco]
Chemical [chem]
variables [qlco]
Cardiovascular disease [dsyn]
influential [idcn]
Total Cholesterol [lbpr]
Chemical [chem]
Values [qlco]
Select [acty]
Objective [inpr]
General Practice [bmod]
setting [ftcn]
Efficacy [qlco]
Effectiveness [qlco]
treatment [ftcn]
Chemical [chem]
risk factors [qnco]
Cardiovascular disease [dsyn]
Design [acty]
DOUBLE BLIND [resa]
placebo [topp]
Controlled Clinical Trial [inpr]
Last [qlco]
months [tmco]
Patients [podg]
Adults [aggp]
Average [qnco]
Dutch Population [popg]
Village [geoa]
Serum cholesterol level [lbpr]
mmol/L [qnco]
mmol/L [qnco]
intervention [hlca]
Subject [grup]
Assigned [ftcn]
RANDOM [resa]
treatment [ftcn]
mg% [qnco]
Daily [tmco]
placebo [topp]
Chemical [chem]
Parameters [fndg]
Assessed [acty]
AT-1 [gngm]
months [tmco]
Efficacy [qlco]
Measured [qlco]
Long-Term Effect [phpr]
Effectiveness [qlco]
Measured [qlco]
Combine [mnob]
2 5 [qnco]
Outcome Measures [qnco]
Total Cholesterol [lbpr]
Primary [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Triglycerides [bacs, lipd]
Apolipoprotein A-1 [aapp, bacs]
Apolipoprotein B100 [aapp, bacs]
Fibrinogen [aapp, bacs, phsu]
Lipoprotein (a) [aapp, bacs]
LP [diap, topp]
secondary [neop]
statistically significant [qnco]
Efficacy [qlco]
Effectiveness [qlco]
Total Cholesterol [lbpr]
Group [idcn]
placebo [topp]
Group [idcn]
Same [qlco]
Chemical [chem]
Values [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
Effectiveness [qlco]
P NOS [aapp, imft]
Conclusions [idcn]
Efficacy [qlco]
Effectiveness [qlco]
Relevance [qlco]
Application [hlca]
Lipid lowering drug [phsu]
General Practice [bmod]
